The short version of mass spectrometry fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-02-10. Anything still debated is marked as such rather than presented as settled.
Lyophilized semaglutide powder is typically held at minus twenty degrees Celsius for long-term storage. At that temperature, solid-state degradation reactions proceed slowly and the peptide remains intact for extended periods. Repeated freeze-thaw cycles are best avoided because they promote aggregation and can shift the proportion of monomeric peptide present. Working aliquots are often prepared so that each portion is thawed only once, and desiccant is placed inside the vial to limit moisture uptake.
Identity and purity are usually assessed by reverse-phase high-performance liquid chromatography coupled to mass spectrometry. Retention time and observed mass are compared against a reference standard run under identical conditions. Impurity profiles reveal deamidation products, oxidized methionine variants, and truncated fragments that arise during synthesis or storage. Peptide mapping through enzymatic digestion confirms the primary sequence, while amino acid analysis offers an independent check on overall composition.
Lyophilized semaglutide is typically stored at temperatures between minus 20 and minus 80 degrees Celsius for long-term preservation. Short-term storage at 2 to 8 degrees Celsius is common for working aliquots. Repeated freeze-thaw cycles can degrade the peptide and are usually avoided. The molecule is hygroscopic in its solid form, so containers should remain sealed with desiccant. Solutions are less stable than powders and are generally prepared fresh. Light exposure is limited because aromatic residues can undergo photo-oxidation.
Semaglutide dissolves readily in water and in aqueous buffers near neutral pH. Solubility decreases near the isoelectric point, where net charge is minimal. Common laboratory solvents include phosphate-buffered saline and dilute ammonium bicarbonate. Strongly acidic or basic conditions may accelerate hydrolysis. Working concentrations are usually prepared by diluting a concentrated stock. Vial surfaces can adsorb small amounts of peptide at low concentrations, so carrier proteins or low-binding tubes are sometimes used.
Reverse-phase high-performance liquid chromatography is the standard method for purity assessment, separating the peptide from truncated or oxidized variants. Mass spectrometry confirms molecular mass and detects modifications, while ultraviolet absorbance near 280 nanometers supports concentration measurement through tryptophan and tyrosine residues. Circular dichroism can indicate secondary structure, though the peptide is largely helical in solution, and ion-exchange chromatography resolves charge variants. Purity values above 95 percent are typical for research-grade material. Stability studies track degradation over time under defined conditions.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white lyophilized powder | Batch-to-batch variation is normal |
| Solubility class | Soluble in water, buffer, and dimethyl sulfoxide | Aqueous solubility is moderate |
| Typical storage temperature | Minus 20 degrees Celsius dry, 2 to 8 degrees Celsius reconstituted | Avoid repeated freeze-thaw |
| Common analytical method | Reverse-phase HPLC with electrospray mass detection | Used for purity and mass confirmation |
| Common synonyms | GLP-1 analog, semaglutide peptide | Wording varies across suppliers |
皮下注射后吸收相对缓慢，绝对生物利用度约为百分之八十九，血药浓度峰值通常出现在给药后一到三天。与白蛋白结合使清除减慢，终末半衰期约为一百六十五小时，接近一周。连续给药约四到五周后达到稳态暴露水平。表观分布容积约为每千克零点二五升，血浆蛋白结合率超过百分之九十九。代谢以蛋白水解切割和脂肪二酸侧链的 β-氧化为主，相关产物主要经尿液与粪便排出。
序列层面的改动同时解决了两个问题，即酶解稳定性与肾脏清除速度。天然 GLP-1 在循环中的半衰期仅约两分钟，主要被二肽基肽酶-4 迅速灭活。酰化侧链与白蛋白的可逆结合形成循环储库，使分子缓慢释放并持续激活受体。这种设计思路后来被广泛用于同类长效肽的开发，属于该类药物化学改造的典型范式。
Clinical development of this compound followed earlier short-acting GLP-1 analogues that required frequent injection. Once-weekly subcutaneous formulations entered use after 2017, and an oral formulation using a permeation enhancer later became available. The oral version pairs the peptide with sodium N-(8-[2-hydroxybenzoyl] amino) caprylate, a carrier that improves uptake across the gastric epithelium. Interest has expanded from glycaemic control into weight management and metabolic liver disease. Regulatory status and approved indications differ between countries, and the product remains subject to ongoing safety monitoring.
Semaglutide is a synthetic peptide that acts as an agonist at the glucagon-like peptide-1 receptor. It is a structural analogue of human GLP-1(7-37), modified to resist enzymatic degradation by dipeptidyl peptidase-4. The peptide backbone contains alpha-aminoisobutyric acid at position 8, a substitution that stabilises the helix and slows cleavage. A fatty diacid side chain attached through a linker at lysine 34 promotes binding to serum albumin, which extends the circulating half-life. These two modifications together allow less frequent administration than native GLP-1 requires.
Activation of the GLP-1 receptor couples to Gs signalling and raises intracellular cyclic AMP in pancreatic beta cells. The resulting insulin release depends on prevailing glucose concentrations, so the effect is greater when glucose is elevated. Receptor engagement also suppresses glucagon secretion and slows gastric emptying, which flattens post-meal glucose excursions. In the central nervous system, signalling in hypothalamic and brainstem regions is associated with reduced appetite and lower energy intake. Studies continue to examine effects on cardiac, renal and hepatic endpoints; whether those benefits are independent of weight change remains an open question.
Receptor activation raises intracellular cyclic AMP through Gs coupling, which promotes glucose-dependent insulin release and suppresses glucagon secretion when blood glucose is elevated. Effects outside the pancreas include slower gastric emptying and altered appetite signalling in the hypothalamus and hindbrain. The relative contribution of each tissue to overall metabolic outcomes remains an area of active investigation. Central mechanisms in particular are inferred mainly from animal models and indirect human measures rather than direct observation.
Serum protein binding dominates the pharmacokinetic profile. The attached chain associates strongly with albumin, shielding the peptide from enzymatic attack and slowing filtration by the kidney. This interaction extends the circulation half-life to roughly one week in humans, which supports weekly administration intervals. An oral version pairs the peptide with an absorption enhancer that transiently alters gastric epithelium, permitting limited uptake; bioavailability by that route is substantially lower than by injection.
Receptor binding triggers G protein signaling that raises intracellular cyclic AMP in pancreatic beta cells. Insulin release follows in a glucose-dependent manner, so secretion increases when blood glucose is elevated and diminishes when it is not. The same signaling suppresses glucagon release from alpha cells and slows gastric emptying, which blunts the post-meal glucose rise. In the brain, receptor activation in regions such as the arcuate nucleus is associated with reduced appetite and lower energy intake. How much each of these effects contributes to overall weight change is not fully settled.
Two structural features account for the prolonged half-life of semaglutide. A modified amino acid at position 8 resists cleavage by dipeptidyl peptidase-4, the enzyme that rapidly degrades native GLP-1. A fatty diacid side chain binds serum albumin, which limits renal clearance and protects the peptide from enzymatic breakdown. These modifications yield a plasma half-life of approximately one week in humans, allowing once-weekly administration. The relationship between plasma concentration and clinical effect varies between individuals, and sources of that variability are still being characterized.
Semaglutide is a synthetic peptide analog of glucagon-like peptide-1 (GLP-1), a hormone released from intestinal L-cells after food intake. The compound belongs to the incretin mimetic class and acts at GLP-1 receptors distributed across pancreatic, gastrointestinal, cardiovascular, and central nervous system tissues. Compared with native GLP-1, the molecule carries structural changes that extend its activity from minutes to roughly one week. It is studied for glycemic control in type 2 diabetes and for weight management, and its effects on cardiovascular and other outcomes remain active research areas.
The restaurants serve Korean food, including kimchi dishes, Pyongyang cold noodles, barbecued cuttlefish and dog meat soup. Patrons may also buy North Korean products such as ginseng wine and an unlabelled aphrodisiac claimed to be made from bears. The prices are relatively high and in US dollars. The staff consists of young Korean women in traditional Chosŏn-ot dress, who also perform karaoke as well as song and dance routines in the style of the North Korean Mass Games for the customers. Staff from North Korea typically work on three-year contracts, and are often highly trained graduates of arts colleges. Photography is generally not permitted inside.
== History == The existence of a compensatory mechanism for telomere shortening was first found by Soviet biologist Alexey Olovnikov in 1973, who also suggested the telomere hypothesis of aging and the telomere's connections to cancer and perhaps some neurodegenerative diseases. Telomerase in the ciliate Tetrahymena was discovered by Carol W. Greider and Elizabeth Blackburn in 1984. Together with Jack W. Szostak, Greider and Blackburn were awarded the 2009 Nobel Prize in Physiology or Medicine for their discovery. Later the cryo-EM structure of telomerase was first reported in T. thermophila, to be followed a few years later by the cryo-EM structure of telomerase in humans. The role of telomeres and telomerase in cell aging and cancer was established by scientists at biotechnology company Geron with the cloning of the RNA and catalytic components of human telomerase and the development of a polymerase chain reaction (PCR) based assay for telomerase activity called the TRAP assay, which surveys telomerase activity in multiple types of cancer. The negative stain electron microscopy (EM) structures of human and Tetrahymena telomerases were characterized in 2013. Two years later, the first cryo-electron microscopy (cryo-EM) structure of telomerase holoenzyme (Tetrahymena) was determined. In 2018, the structure of human telomerase was determined through cryo-EM by UC Berkeley scientists.
Neurochemistry – study of neurochemicals; including transmitters, peptides, proteins, lipids, sugars, and nucleic acids; their interactions, and the roles they play in forming, maintaining, and modifying the nervous system. Molecular biochemistry and genetic engineering – an area of biochemistry and molecular biology that studies the genes, their heritage and their expression. Bioorganic chemistry – combines organic chemistry and biochemistry toward biology. Biophysical chemistry – is a physical science that uses the concepts of physics and physical chemistry for the study of biological systems. Medicinal chemistry – discipline which applies chemistry for medical or drug related purposes. Organometallic chemistry – is the study of organometallic compounds, chemical compounds containing at least one chemical bond between a carbon atom of an organic molecule and a metal, including alkaline, alkaline earth, and transition metals, and sometimes broadened to include metalloids like boron, silicon, and tin. Physical organic chemistry – study of the interrelationships between structure and reactivity in organic molecules. Inorganic chemistry – study of the properties and reactions of inorganic compounds. The distinction between organic and inorganic disciplines is not absolute and there is much overlap, most importantly in the sub-discipline of organometallic chemistry. Bioinorganic chemistry – is a field that examines the role of metals in biology.
Sources: en.wikipedia.org
Advanced Simulation Library Droplet-based microfluidics Fluidics Induced-charge electrokinetics Integrated fluidic circuit Lab-on-a-chip Microfluidic cell culture Microfluidic modulation spectroscopy Microphysiometry Micropumps Microvalves uFluids@Home Paper-based microfluidics
Xi's foreign policy thoughts are collectively known as Xi Jinping Thought on Diplomacy. Xi has promoted major-country diplomacy, stating that China is already a "big power" and breaking away from previous Chinese leaders who had a more precautious diplomacy. Diplomats under Xi have adopted a hawkish foreign policy posture called "wolf warrior diplomacy" starting from the late 2010s; this form of diplomacy peaked in the early 2020s and declined afterwards. Xi frequently says that the world is seeing "great changes unseen in a century", referring to geopolitical shifts in which the United States is seen as a declining power and in which the rise of populism, economic securitization, and advancing technology create an environment of uncertainty that results in both opportunities and threats for China. In October 2020, he said that "the East is rising and the West is declining", saying that the power of the Western world was in decline as exemplified by their COVID-19 response, and that China was entering a period of opportunity because of this. Xi has frequently alluded to community with a shared future for mankind, which Chinese diplomats have said does not imply an intention to change the international order, but which foreign observers say China wants a new order that puts it more at the centre. During the Xi administration, China seeks to shape international norms and rules in emerging policy areas where China has an advantage as an early participant.
Clinical Chemistry is a peer-reviewed medical journal covering the field of clinical chemistry. It is the official journal of the American Association for Clinical Chemistry. The journal was first published in 1955 on a bi-monthly basis "to raise the level at which chemistry is practiced in the clinical laboratory"; monthly publication commenced in 1964. The editor-in-chief is Nader Rifai (Harvard Medical School).
1,1'-Carbonyldiimidazole (CDI) is an organic compound with the molecular formula (C3H3N2)2CO. It is a white crystalline solid. It is often used for the coupling of amino acids for peptide synthesis and as a reagent in organic synthesis.
Sources: en.wikipedia.org
== History == The enzyme classification and nomenclature list was first approved by the International Union of Biochemistry in 1961. Six enzyme classes had been recognized based on the type of chemical reaction catalyzed, including oxidoreductases (EC 1), transferases (EC 2), hydrolases (EC 3), lyases (EC 4), isomerases (EC 5) and ligases (EC 6). However, it became apparent that none of these could describe the important group of enzymes that catalyse the movement of ions or molecules across membranes or their separation within membranes. Several of these involve the hydrolysis of ATP and had been previously classified as ATPases (EC 3.6.3.-), although the hydrolytic reaction is not their primary function. In August 2018, the International Union of Biochemistry and Molecular Biology classified these enzymes under a new enzyme class (EC) of translocases (EC 7).
During the events of the crossover film Tokusou Sentai Dekaranger vs. Abaranger, Trinoid #0 Saunaginnan resurrects Ben G, who is subsequently killed by Deka Master, Pink, and Break, as well as Abare Killer. Ben G is voiced by Nobuyuki Hiyama (檜山 修之, Hiyama Nobuyuki). Cristonian Ferley (クリスト星人ファーリー, Kurisuto Seijin Fārī): A werewolf/vampire bat–themed criminal from Planet Cristo who is charged with burglary and murdering several S.P.D. officers. As his body is photosensitive, he tasks a Batsuroid with piloting a Kaijuki called Devil Capture 4 (デビルキャプチャー4, Debiru Kyapuchā Fō) to distract the Dekarangers while Ferley locates and eats a mineral called Lunar Metal so he can roam freely in daylight. Devil Capture 4 is destroyed by Dekaranger Robo while Ferley is deleted by the Dekarangers via the D-Bazooka. In the direct-to-video special Tokusou Sentai Dekaranger Super Video: Super Finisher Match! Deka Red vs. Deka Break, a variation of Ferley called Burning Ferley (バーニング・ファーリー, Bāningu Fārī) appears as part of a simulation training session. Ferley is voiced by Hisao Egawa (江川 央生, Egawa Hisao). Titarnian Metiussl (ティタン星人メテウス, Titan Seijin Meteusu): A brutal flame/astronaut–themed criminal and self-proclaimed "Destroyer King" (破壊王, Hakaiō) from Planet Titarn who seeks out an android girl named Flora, whom he created to control his giant creation Machine Monster Gigas (マシンモンスター・ギーガス, Mashin Monsutā Gīgasu). He tasks a Batsuroid with piloting a gladiator-themed Kaijuki called Cannon Gladiator (キャノングラディエーター, Kyanon Guradiētā) and attacking the Deka Base while he locates Flora.
Generative artificial intelligence (GenAI) is a subfield of artificial intelligence (AI) that uses generative models to generate text, images, videos, audio, computer code or other forms of digital data. These models learn the underlying patterns and structures of their training data, and use them to generate new data in response to input, which often takes the form of natural language prompts. The prevalence of generative AI tools has increased significantly since the AI boom of the early 2020s. This boom was made possible by improvements in deep neural networks, particularly large language models (LLMs), which are based on the transformer architecture. Generative AI applications include chatbots such as ChatGPT, Claude, Microsoft Copilot, DeepSeek, Doubao, Google Gemini, Grok, Kimi and Qwen; text-to-image models such as DALL-E, Firefly, Stable Diffusion, and Midjourney; and text-to-video models such as Veo, LTX and Sora. Companies in a variety of sectors have used or proposed the use of generative AI, including those in software development, healthcare, finance, entertainment, sales and marketing, screenwriting, and product design. Generative AI has been used for cybercrime, and to deceive and manipulate people through fake news and deepfakes. Generative AI models have been trained on copyrighted works without the rightholders' permission. Many generative AI systems are reliant on large-scale data centers, whose environmental impacts include electronic waste, consumption of fresh water for cooling, and high energy consumption that is estimated to be growing steadily.
Methylergometrine, also known as methylergonovine and sold under the brand name Methergine, is a medication of the ergoline and lysergamide groups which is used as an oxytocic in obstetrics and as an antimigraine agent in the treatment of migraine headaches. It reportedly produces psychedelic effects similar to those of lysergic acid diethylamide (LSD) at high doses.
From the records of St. Francis' physical ailments and symptoms, Edward Frederick Hartung concluded in 1935 that St. Francis had an eye ailment known as trachoma and quartan malaria. Quartan malaria infects the liver, spleen, and stomach, causing the victim intense pain. One complication of quartan malaria is known as purpura, a purple hemorrhage of blood into the skin. According to Hartung "If this were the case of St. Francis, he would have been afflicted by ecchymoses, an exceedingly large purpura. The purple spots of blood may have been punctured while in the wilderness and there appear as an open wound like that of Christ." A later medical hypothesis was proposed in 1987 to explain the wounds, it claimed that St. Francis may have contracted leprosy.
Sources: en.wikipedia.org
Manufacturers commonly state multi-year stability when the powder is kept dry and frozen. Actual shelf life depends on residual moisture, vial sealing, and storage temperature. A re-test by chromatography is the only way to confirm remaining purity.
Deamidated and oxidized forms are the most frequently reported impurities. Truncated peptide fragments from incomplete synthesis also appear at low levels. Their relative abundance grows with time, heat exposure, and unfavorable pH.
Retention time matching on a validated column provides strong circumstantial evidence. It does not distinguish compounds with similar hydrophobicity. Mass measurement or peptide mapping is needed for unambiguous identification.
Long-term storage is usually at minus 20 to minus 80 degrees Celsius in a sealed, desiccated container. Working aliquots can be held briefly at 2 to 8 degrees Celsius.